Evaluation of the WHO criteria for antiretroviral treatment failure among adults in South Africa

AIDS

Volumn 22, Issue 15, 2008, Pages 1971-1977

  Mee, Paul ^a,c   Fielding, Katherine L ^a   Charalambous, Salome ^b   Churchyard, Gavin J ^a,b   Grant, Alison D ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b AURUM INSTITUTE   (South Africa)

^c MRC CLINICAL TRIALS UNIT   (United Kingdom)

Author keywords

Antiretroviral therapy; Developing countries; Drug monitoring; HIV infections

Indexed keywords

ANTIRETROVIRUS AGENT; EFAVIRENZ; LAMIVUDINE; NEVIRAPINE; STAVUDINE; ZIDOVUDINE;

ADULT; ARTICLE; BACTERIAL PNEUMONIA; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; DRUG TREATMENT FAILURE; ENTERITIS; EXTRAPULMONARY TUBERCULOSIS; FEMALE; GOLD STANDARD; HEALTH PROGRAM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKOPLAKIA; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; PREDICTIVE VALIDITY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SINUSITIS; SOUTH AFRICA; THRUSH; VIROLOGY; VIRUS INHIBITION; VIRUS LOAD; WEIGHT REDUCTION; WORLD HEALTH ORGANIZATION;

ADULT; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; DEVELOPING COUNTRIES; DRUG MONITORING; DRUG RESISTANCE, VIRAL; EPIDEMIOLOGIC METHODS; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; TREATMENT FAILURE; VIRAL LOAD; WORLD HEALTH ORGANIZATION;

EID: 53549099373     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAD.0b013e32830e4cd8     Document Type: Article

References (15)

1. World Health Organisation. World Health Organisation treating 3 million by 2005: making it happen: the WHO strategy: the WHO and UNAIDSglobal initiative to provide antiretroviral therapy to 3 million people with HIV/AIDS in developing countries by the end of 2005/Treat 3 Million by 2005. http://libdoc.who.int/publica-tions/2003/9241591129.pdf. [Accessed 2 June 2008].
2. World Health Organisation. World Health Organisation Scaling up anti-retroviral therapy in resource limited settings. A public health approach, http://www.who.int/hiv/pub/prev_care/en/ arvrevision2003en.pdf. [Accessed 2 June 2008].
3. World Health Organisation. World Health Organisation Antiretroviral therapy in adults and adolescents - recommendations for a public health approach - 2006 revision. http://www. who.int/hiv/pub/guidelines/artadultguidelines.pdf. [Accessed 2 June 2008].
4. Gilks CF, Crowley S, Ekpini R, Gove S, Perriens J, Souteyrand Y, et al. The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings. Lancet 2006; 368:505-510.
5. Charalambous S, Grant AD, Day JH, Rothwell E, Chaisson RE, Hayes RJ, Churchyard GJ. Feasibility and acceptability of a specialist clinical service for HIV-infected mineworkers in South Africa. AIDS Care 2004; 16:47-56.
6. Charalambous S, Grant AD, Day JH, Pemba L, Chaisson RE, Kruger P, et al. Establishing a workplace antiretroviral therapy programme in South Africa. AIDS Care 2007; 19:34-41.
7. Murri R, Lepri AC, Cicconi P, Poggio A, Arlotti M, Tositti G, et al. Is moderate HIV viremia associated with a higher risk of clinical progression in HIV-infected people treated with highly active antiretroviral therapy: evidence from the Italian cohort of antiretroviral-naive patients study. J Acquir Immune Defic Syndr 2006; 41:23-30.
8. Clopper CJ, Pearson ES. The use of confidence or fiducial limits illustrated in the case of the binomial. Biometrika 1934; 26:404-413.
9. Colebunders R, Moses KR, Laurence J, Shihab HM, Semitala F, Lutwama F, et al. A new model to monitor the virological efficacy of antiretroviral treatment in resource-poor countries. Lancet Infect Dis 2006; 6:53-59.
10. Deeks SG, Barbour JD, Grant RM, Martin JN. Duration and predictors of CD4 T-cell gains in patients who continue combination therapy despite detectable plasma viremia. AIDS 2002; 16:201-207.
11. Akileswaran C, Lurie MN, Flanigan TP, Mayer KH. Lessons learned from use of highly active antiretroviral therapy in Africa. Clin Infect Dis 2005; 41:376-385.
12. Rosen S, Fox MP, Gill CJ. Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PLoS Med 2007; 4:e298.
13. Moore DM, Mermin J, Awor A, Yip B, Hogg RS, Montaner JS. Performance of immunologic responses in predicting viral load suppression: implications for monitoring patients in resource-limited settings. J Acquir Immune Defic Syndr 2006; 43:436-439.
14. Bisson GP, Gross R, Strom JB, Rollins C, Bellamy S, Weinstein R, et al. Diagnostic accuracy of CD4 cell count increase for virologic response after initiating highly active antiretroviral therapy. AIDS 2006; 20:1613-1619.
15. Chaiwarith R, Wachirakaphan C, Kotarathititum W, Praparatanaphan J, Sirisanthana T, Supparatpinyo K. Sensitivity and specificity of using CD4+ measurement and clinical evaluation to determine antiretroviral treatment failure in Thailand. Int J Infect Dis 2007; 11:413-416.